Your browser doesn't support javascript.
loading
ISHLT Primary Graft Dysfunction Incidence, Risk Factors, and Outcome: A UK National Study.
Avtaar Singh, Sanjeet Singh; Banner, Nicholas R; Rushton, Sally; Simon, Andre R; Berry, Colin; Al-Attar, Nawwar.
Afiliação
  • Avtaar Singh SS; Cardiothoracic Surgery, Golden Jubilee National Hospital, Glasgow, United Kingdom.
  • Banner NR; Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom.
  • Rushton S; Transplant and Mechanical Circulatory Support, Harefield Hospital, London, United Kingdom.
  • Simon AR; Statistics and Clinical Studies, National Health Service Blood and Transplant (NHSBT), Bristol, United Kingdom.
  • Berry C; Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom.
  • Al-Attar N; Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom.
Transplantation ; 103(2): 336-343, 2019 02.
Article em En | MEDLINE | ID: mdl-29757910
BACKGROUND: Heart transplantation (HTx) remains the most effective long-term treatment for advanced heart failure. Primary graft dysfunction (PGD) continues to be a potentially life-threatening early complication. In 2014, a consensus statement released by International Society for Heart and Lung Transplantation (ISHLT) established diagnostic criteria for PGD. We studied the incidence of PGD across the United Kingdom. METHODS: We analyzed the medical records of all adult patients who underwent HTx between October 2012 and October 2015 in the 6 UK heart transplant centers Preoperative donor and recipient characteristics, intraoperative details, and posttransplant complications were compared between the PGD and non-PGD groups using the ISHLT definition. Multivariable analysis was performed using logistic regression. RESULTS: The incidence of ISHLT PGD was 36%. Thirty-day all-cause mortality in those with and without PGD was 31 (19%) versus 13 (4.5%) (P = 0.0001). Donor, recipient, and operative factors associated with PGD were recipient diabetes mellitus (P = 0.031), recipient preoperative bilateral ventricular assist device (P < 0.001), and preoperative extracorporeal membranous oxygenation (P = 0.023), female donor to male recipient sex mismatch (P = 0.007), older donor age (P = 0.010), and intracerebral haemorrhage/thrombosis in donor (P = 0.023). Intraoperatively, implant time (P = 0.017) and bypass time (P < 0.001) were significantly longer in the PGD cohort. Perioperatively, patients with PGD received more blood products (P < 0.001). Risk factors identified by multivariable logistic regression were donor age (P = 0.014), implant time (P = 0.038), female: male mismatch (P = 0.033), recipient diabetes (P = 0.051) and preoperative ventricular assist device/extracorporeal membranous oxygenation support (P = 0.012). CONCLUSIONS: This is the first national study to examine the incidence and significance of PGD after HTx using the ISHLT definition. PGD remains a frequent early complication of HTx and is associated with increased mortality.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Coração / Disfunção Primária do Enxerto Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Coração / Disfunção Primária do Enxerto Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article